Restasis for Treatment of Brittle Nails

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

December 31, 2012

Conditions
Brittle Nails
Interventions
DRUG

Restasis (cyclosporine ophthalmic emulsion) 0.05%

cyclosporine ophthalmic emulsion 0.05%

DRUG

Refresh® Dry Eye therapy

Emulsion contains glycerin 1% and polysorbate 80

Trial Locations (1)

10032

Columbia University Medical Center Department of Dermatology, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Julian M. Mackay-Wiggan

OTHER